These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 13703180)

  • 1. [Effect of a heparinoid extracted from duodenal mucosa on total cholesterolemia in atherosclerosis].
    GALLO E; SERRA GC
    Minerva Cardioangiol; 1960 Aug; 8():395-8. PubMed ID: 13703180
    [No Abstract]   [Full Text] [Related]  

  • 2. [Statistical considerations on cholesterolemia in atherosclerosis].
    ASCHIERI F; AGRIFOGLIO G
    Minerva Cardioangiol; 1958 Feb; 6(2):115-8. PubMed ID: 13552006
    [No Abstract]   [Full Text] [Related]  

  • 3. HEPARIN-LIKE SUBSTANCES AND ATHEROSCLEROSIS; A CLINICAL SURVEY AFTER FOUR YEARS OF THERAPEUTIC USE OF A DUODENAL HEPARINOID.
    COSTA U; AZZENA D; ASTENGO F; GHIGLIOTTI G
    G Gerontol; 1964 Feb; 12():201-2. PubMed ID: 14163031
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of heparin on cholesterol partition, lipoproteins and atherosclerosis in experimental hypercholesterolemia.
    MOSES C; RHODES GL
    Angiology; 1954 Oct; 5(5):429-32. PubMed ID: 13197814
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heparin, cholesterol & plasma protein values in the general evolution of atherosclerosis].
    PESCADOR L; OUTEIRINO J; MARTIN DE PRADOS B; SAINZ V
    Acta Cardiol; 1957; 12(4):402-6. PubMed ID: 13468992
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental cholesterin atherosclerosis in the rabbit: action of a duodenal heparinoid. III. Modifications in the factors of hemocoagulation, plasmin and plasminogen, and in the thromboplastin and fibrinolytic activity of the aortic wall].
    SOARDI F; NICROSINI F; DEL FAVERO A; PASOTTI C
    Farmaco Prat; 1961 Nov; 16():560-8. PubMed ID: 14039393
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of fat ingestion and heparin administration on serum lipids of normal hypercholesterolemic, hyperlipemic and atherosclerotic subjects.
    JOYNER CR; KUO PT; REINHOLD JG
    Am J Med Sci; 1956 Dec; 232(6):613-23. PubMed ID: 13372533
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical aspects of the hypocholesterolemic and clearing action of a heparinoid and its relation to atherosclerosis].
    ALMAFARA ML; ORLANDO MM
    Sem Med; 1962 Mar; 120():433-6. PubMed ID: 13860649
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental analysis of the interactions between heparin and a duodenal heparinoid].
    Marmo E; Lampa E; Vacca C; Rossi F; Spadaro R; Sannino A
    Arch Sci Med (Torino); 1975; 132(3):83-115. PubMed ID: 56927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of heparin on total, free and esterified cholesterol in arteriosclerosis].
    PICCARDO MG; GUARINI G
    Boll Soc Ital Biol Sper; 1956; 32(7-8):729-31. PubMed ID: 13404120
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma clearing capacity & changes in blood cholesterol levels after intravenous injections of heparin in diabetes & atherosclerosis].
    STORK A; KUCEROVA L
    Dtsch Med Wochenschr; 1957 Aug; 82(35/I):1410-3. PubMed ID: 13461649
    [No Abstract]   [Full Text] [Related]  

  • 12. [Importance of fluctuating cholesterolemia for the development of Experimental atherosclerosis in rats (author's transl)].
    Záhor Z; Czabanová V; Bilyk I
    Sb Lek; 1981 Apr; 83(4):89-99. PubMed ID: 7256173
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cholesterol and its beta and alpha heparinoid fractions in normal and atheromatous subjects].
    Bidoggia H; Aguilo B; Moreton E; Leguizamon E; de Gracia E
    Rev Atheroscler (Paris); 1969; 11(2):70-8. PubMed ID: 5403124
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical changes of blood in atherosclerosis and in old age with particular reference to mucopolysaccharides and heparinoid substances.
    ANTONINI FM
    Experientia; 1956; (Suppl 4):176-80. PubMed ID: 13414752
    [No Abstract]   [Full Text] [Related]  

  • 15. [Semeiological significance of total cholesterolemia in atherosclerotic patients].
    FONNESU V
    Boll Soc Ital Biol Sper; 1961 Feb; 37():138-40. PubMed ID: 13700587
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clearing capacity of blood plasma after intravenous heparin injection in its relation to atherosclerosis].
    STORK A; KUCEROVA L
    Z Gesamte Inn Med; 1956 Mar; 11(6):276-8. PubMed ID: 13353271
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heparin-induced changes in relation to the total cholesterol/phospholipid ratio in normal subjects and in arteriosclerosis patients].
    GUARINI G
    Boll Soc Ital Biol Sper; 1956; 32(7-8):724-5. PubMed ID: 13404117
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of dextro-thyroxine and androsterone on blood cholesterol and coagulation factors in atherosclerosis].
    DUFAULT C; TREMBLAY G; NOWACZYNSKI W; GENEST J
    Union Med Can; 1961 Dec; 90():1351-64. PubMed ID: 13888219
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute lipidemic effect of calcium heparin in normolipemic and hyperlipemic subjects.
    Ferlito S; Ricceri M; Ossino AM
    Int Angiol; 1989; 8(3):140-4. PubMed ID: 2592796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of dextro-thyroxine and androsterone on blood clotting factors and serum cholesterol in patients with atherosclerosis.
    DUFAULT C; TREMBLAY G; NOWACZYNSKI W; GENEST J
    Can Med Assoc J; 1961 Nov; 85(19):1025-31. PubMed ID: 13888218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.